These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6827127)

  • 1. Decreased urinary polyamines in patients with psoriasis treated with etretinate.
    Grekin RC; Ellis CN; Goldstein NG; Swanson NA; Anderson TF; Duell EA; Voorhees JJ
    J Invest Dermatol; 1983 Mar; 80(3):181-4. PubMed ID: 6827127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of increased polyamine levels in psoriatic lesions by retinoid and PUVA treatments.
    Lauharanta J; Kousa M; Kapyaho K; Linnamaa K; Mustakallio K
    Br J Dermatol; 1981 Sep; 105(3):267-72. PubMed ID: 7272207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etretinate therapy for psoriasis: clinical responses, remission times, epidermal DNA and polyamine responses.
    Kaplan RP; Russell DH; Lowe NJ
    J Am Acad Dermatol; 1983 Jan; 8(1):95-102. PubMed ID: 6826812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lowered cutaneous and urinary levels of polyamines with clinical improvement in treated psoriasis.
    Proctor MS; Wilkinson DI; Orenberg EK; Farber EM
    Arch Dermatol; 1979 Aug; 115(8):945-9. PubMed ID: 464623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etretinate treatment for psoriasis inhibits epidermal ornithine decarboxylase.
    Lowe NJ; Kaplan R; Breeding J
    J Am Acad Dermatol; 1982 Apr; 6(4 Pt 2 Suppl):697-8. PubMed ID: 7068977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical, ultrastructural and biochemical effects of an aromatic retinoid (etretinate) on psoriasis and Darier's disease.
    Lauharanta J
    Acta Derm Venereol Suppl (Stockh); 1982; 101():1-29. PubMed ID: 6954822
    [No Abstract]   [Full Text] [Related]  

  • 7. Urinary polyamine levels in patients with psoriasis.
    Sakakibara S; Yoshikawa K
    Arch Dermatol Res; 1979 Jun; 265(2):133-7. PubMed ID: 464659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of epidermal polyamines to orally administered aromatic retinoid RO 10-9359.
    El Baze P; Milano G; Verrando P; Renee N; Ortonne JP
    Arch Dermatol Res; 1984; 276(2):99-101. PubMed ID: 6721578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acitretin versus etretinate in psoriasis. Clinical and pharmacokinetic results of a German multicenter study.
    Gollnick H; Bauer R; Brindley C; Orfanos CE; Plewig G; Wokalek H; Hoting E
    J Am Acad Dermatol; 1988 Sep; 19(3):458-68. PubMed ID: 2971692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response of psoriatic nails to the aromatic retinoid etretinate.
    Rabinovitz HS; Scher RK; Shupack JL
    Arch Dermatol; 1983 Aug; 119(8):627-8. PubMed ID: 6870312
    [No Abstract]   [Full Text] [Related]  

  • 11. [Combined oral retinoid and PUVA therapy in the treatment of psoriasis and psoriatic arthropathy (author's transl)].
    Thivolet J; Robart S; Vignon E
    Ann Dermatol Venereol; 1981; 108(2):131-7. PubMed ID: 6972721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etretinate therapy for psoriasis. Reduction of antibody-dependent cell-mediated cytotoxicity of polymorphonuclear leukocytes.
    Ellis CN; Kang S; Grekin RC; LoBuglio AF; Voorhees JJ
    Arch Dermatol; 1985 Jul; 121(7):877-80. PubMed ID: 4015133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etretinate therapy improves psoriasis but elevates serum lipids.
    Cowart VS
    JAMA; 1982 May; 247(19):2647-8. PubMed ID: 7077753
    [No Abstract]   [Full Text] [Related]  

  • 14. Keratin polypeptide profile in psoriatic epidermis normalized by treatment with etretinate (aromatic retinoid Ro 10-9359).
    Staquet MJ; Faure MR; Reano A; Viac J; Thivolet J
    Arch Dermatol Res; 1983; 275(2):124-9. PubMed ID: 6191725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinical evaluation of the effects of an aromatic retinoid (Tigason), combination of retinoid and PUVA, and PUVA alone in severe psoriasis.
    Lauharanta J; Juvakoski T; Lassus A
    Br J Dermatol; 1981 Mar; 104(3):325-32. PubMed ID: 7011359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etretinate therapy stimulates deposition of mucus-like material in epidermis of patients with psoriasis.
    Ellis CN; Gold RC; Grekin RC; Anderson TF; Swanson NA; Voorhees JJ
    J Am Acad Dermatol; 1982 Apr; 6(4 Pt 2 Suppl):699-704. PubMed ID: 7068978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etretinate therapy reduces polymorphonuclear leukocyte chemotaxis--enhancing properties of psoriatic serum.
    Ellis CN; Kang S; Grekin RC; Voorhees JJ; Silva J
    J Am Acad Dermatol; 1985 Sep; 13(3):437-43. PubMed ID: 4056118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methotrexate and etretinate as concurrent therapies in severe psoriasis.
    Vanderveen EE; Ellis CN; Campbell JP; Case PC; Voorhees JJ
    Arch Dermatol; 1982 Sep; 118(9):660-2. PubMed ID: 7114868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etretinate therapy causes increases in lipid levels in patients with psoriasis.
    Ellis CN; Swanson NA; Grekin RC; Goldstein NG; Bassett DR; Anderson TF; Voorhees JJ
    Arch Dermatol; 1982 Aug; 118(8):559-62. PubMed ID: 7103524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acitretin (Ro 10-1670) in the treatment of severe psoriasis. A randomized double-blind parallel study comparing acitretin and etretinate.
    Ledo A; Martín M; Geiger JM; Marrón JM
    Int J Dermatol; 1988 Nov; 27(9):656-60. PubMed ID: 2976406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.